1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsRFA 20620 - Expanding Harm Reduction Services for Priority Populations Who Use Drugs - Reissue Grant is sponsored by New York State Department of Health. Funding for harm reduction services targeting vulnerable populations, including adolescents, young adults, and veterans who use drugs, in New York State.
Get alerted about grants like this
Get emailed when new opportunities from “New York State Department of Health” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Grant | Expanding Harm Reduction Services for Priority Populations Who Use Drugs (Deadline October 3, 2023) - Hep Free NYC Public Education Materials Viral Hep Elimination Hub Grant | Expanding Harm Reduction Services for Priority Populations Who Use Drugs (Deadline October 3, 2023) A network building capacity to prevent, manage and treat hepatitis B and C in NYC Expanding Harm Reduction Services for Priority Populations Who Use Drugs NYS Health Dept – AIDS Institute, Office of Drug User Health Grant Opportunity ID: DOH01-PPHRS-2024 Application Deadline: October 3, 2023 by 4 PM ET Expected number of awards: 8 – 24 (200,00 -300,000 each) Estimated Total Program Funding: Up to $3,750,000 annually for 2 years The intent of this funding is to fund agencies in NYS, who work closely and provide support to People Who Use Drugs (PWUD) and these priority populations by providing harm reduction services and activities using a heath equity lens and framework.
The applicants need to demonstrate how they plan to expand the array of meaningful, non-coercive, client-driven services to reduce overdose and other negative outcomes of substance use.
These activities could include direct services to people who use drugs, and either directly provided or via linkage to outside providers, access to medications for opioid use disorder/medications for addiction treatment (MOUD/MAT), as well as the provision of naloxone, training, and overdose prevention materials.
All applicants should describe how the programs will address the social determinants of health (SDOH) that contribute to perpetuating an individual’s vulnerability to repeated overdose, such as lack of stable housing, poverty, drug-use related stigma, racism, etc. Studies have shown that the increasing number of cumulative reports of non-fatal overdose are associated with a greater risk of subsequent fatal overdose.
Therefore, each non-fatal overdose significantly increases a person’s risk of a subsequent fatal overdose. This highlights the importance of and need for engagement with people who have experienced a recent overdose.
This funding is for programs that can demonstrate they prioritize health and racial equity and can apply a culturally comprehensive, harm reduction and trauma-informed approach when working with PWUD and priority populations. This includes incorporating peer specialists into the program’s staffing.
Peer specialists are persons with recent lived and/or living experience of substance use, who represent the priority population and utilize a harm reduction, trauma-informed approach, have rapport and mutual respect established with PWUD and have experience working with individuals that have complex needs and their networks. Peer specialists support PWUD navigate accessing supportive services and address barriers to timely care.
Their work is to provide non-clinical, strengths‐based support, harm reduction services and linkage to care. View more details of funding here .
Minimum Eligibility Requirement: All applicants must meet the following minimum eligibility requirements: Applicant must be a not-for-profit agency in New York State (NYS) including hospitals, health care systems, primary care networks, academic institutions, community-based organizations, voluntary associations, voluntary agencies that operate OASAS-certified, funded or otherwise authorized SUD treatment programs, voluntary agencies that operate OMH-licensed mental health services programs, scientific /professional associations or be a local government/public health agency.
Applicant must submit Attachment 2 – Statement of Assurances signed by the Chief Executive Officer (CEO) or Designee to certify the organization meets all criteria listed on Attachment 2. Attachment 2 is located in the Pre-Submission Uploads section of the Grants Gateway and once completed should be uploaded in the same section.
Applicant must be prequalified in the New York State Grants Gateway, if not exempt, on the date applications are due.
Requirements for the Program Funded applicants will be expected to implement the following activities and services: Identify and serve a cross-section of clients who are representative of the overall priority population: groups/subgroups at risk for drug overdose, those at high risk for overdose death; and those at disproportionate risk of drug overdose who experience racial/ethnic or socioeconomic disparities (inadequate access to care, poor quality of care, or low income).
Connect with your region’s DUHH/SSP and treatment providers to enhance the availability and accessibility of Medication for Opioid Use Disorder/ Medication for Addiction Treatment (MOUD/MAT) and Hepatitis C care and treatment for PWUD. Invite and meaningfully include PWUD in policy and program development, decision-making, and in advisory roles on committees.
Ensure at least one (1) peer specialist or staff that is a PWLE and represents the priority population is part of the decision-making and delivery of this new initiative. Develop a support system for peers and staff that includes wellness checks and system to address vicarious trauma or other mental health needs. Develop protocols for training and ongoing professional development for peers.
Coordinate services with other health and human service providers, including mental health services, serving the priority population(s). Collaborate with local health departments, regional offices of the NYSDOH as well as other health and human service providers in identifying and responding to emerging trends.
Demonstrate engagement with individuals that have recently experienced an overdose as part of rapid response efforts to suspected overdose spike.
Participate in a collaborative process with the NYSDOH AI to assess progress meeting the initiative standards and program outcomes and provide monthly narrative reports describing the program with respect to 1) model implementation, 2) client identification, engagement, and retention 3) success in meeting the workplan objectives, tasks and performance measures for the RFA, 4) data collection and reporting 5) significant accomplishments achieved, and 6) barriers encountered and plans to address noted problems.
Submit statistical reports on clients served, and other data using the AIDS Institute Reporting System (AIRS). Successful applicants must demonstrate the capacity to collect and report all required data, both personnel and hardware-related using AIRS. AIRS is a data reporting system that is required by the NYSDOH AI to report client demographic information as well as program activities.
NYSDOH AI requires maintenance and reporting of unduplicated client level data, including demographics and service histories, in accordance with applicable federal and/or state reporting requirements. NYSDOH AI provides and supports the AIRS software to enable providers to meet data submission requirements. Details on this software product may be obtained by accessing the following Internet address, www.
airsny. org . Address and assess the specific social and/or structural determinants of health.
The unequal distribution of social and/or determinants can lead to disparities and ultimately inequities in health and health outcomes. Strategies should prioritize those populations that are most impacted, negatively, by social and structural determinants of health. Please see Attachment 4 for Health Equity Definitions and Examples of social and structural determinants of health.
All activities will have a framework of Health Equity. The funded applicant must demonstrate a commitment to health equity: Health equity is the fair and just opportunity for everyone to achieve optimal holistic health and well-being regardless of social position or other social or structural determinants of health.
This requires addressing avoidable inequalities (e.g., access to affordable and high-quality food, housing, education, health care/services, and safe environments), historical and contemporary injustices (e.g., economic injustice/poverty, racism, classism, ableism, sexism, homophobia, transphobia, xenophobia, and other forms of oppression, discrimination, and/or stigma) and valuing health differences equally.
We also acknowledge the historical and structural underpinnings of race, racism, and genocide in the United States that perpetuate many of the racial inequities we see manifested today. Because health equity can never truly be achieved without racial equity, we work toward achieving both.
Ensure all activities are inclusive of populations disproportionately affected by drug overdose and death, and that the needs of persons with disabilities, co-occurring mental health, people with limited health literacy, racial and ethnic groups, and the LGBTQI+ populations are included in activities.
Complete the 12-module, free online Health Equity in the Response to Drug Overdose Training that was funded by the National Association of County and City Health Officials (NACCHO) and the CDC and submit their completion certificate to the NYSDOH. Adhere to Health Literacy Universal Precautions ( https://www. ahrq.
gov/professionals/qualitypatient-safety/quality-resources/tools/literacy-toolkit/index. html ).
Adhere to all objectives, tasks and performance measures as listed in the Work Plan Identify and serve a cross-section of clients who are representative of the overall priority population: groups/subgroups at risk for drug overdose, those at high risk for overdose death; and those at disproportionate risk of drug overdose who experience racial/ethnic or socioeconomic disparities (inadequate access to care, poor quality of care, or low income) within the selected community.
Participate in a collaborative process with the NYSDOH AI to assess program outcomes and provide quarterly narrative reports and performance measures, monthly check-in meetings and monthly office hours with all funded programs.
Programs are expected to describe their progress with respect to 1) Implementation of interventions/services, 2) client recruitment, 3) success in meeting the NYSDOH AI – Work Plan Attachment 5 significant accomplishments achieved, and 5) barriers encountered and plans to address noted problems. On the Grants Gateway home page, click the “View Opportunities” button”.
Use the search fields to locate an opportunity; search by State agency (NYSDOH) or enter the Grant Opportunity name: Expanding Harm Reduction Services for Priority Populations Who Use Drugs . Click on “Search” button to initiate the search.
Click on the name of the Grant Opportunity from the search results grid and then select the “APPLY FOR GRANT OPPORTUNITY” button located bottom left of the Main page of the Grant Opportunity Questions? Contact Narelle Ellendon at PriorityPopsRFA@health. ny.
gov View details of Grant Funding here Last Updated on October 5, 2023 by HepFree NYC Funding | Youth & Young Adults in Recovery Mini-Grants (Due 12/8/17) NYS OASAS, through Research Foundation for Mental Hygiene, is pleased to announce one-time funding of up to $12,000 to support Youth and Young Adults Recovery activities and/or development of communities of recovery.
Funding | Best Practices in Hep B Education Outreach (Due 1/29/16) Funding , Asian American , Hepatitis B The National Task Force on Hepatitis B is offering seven $3,000 awards to recognize hepatitis B education outreach projects by member organizations.
4-30-14 NYC Hep B Coalition Meeting Notes Funding , Meeting Notes , Hep B Coalition Committee View full Meeting Highlights here Maimonides Medical Center – Hep B Services & Observations James Park, MD, Specializes in Transplant Hepatology (jpark2@maimonidesmed. org) Kevin Tin, MD, MBA, Resident – Dept. of Medicine (Ktin@maimonidesmed.
org) Janice Yang, Director... Funding | Hep C Learning Collaborative for Substance Use Disorder Treatment Programs (Deadline February 27, 2024) Funding | Hep C Micro-Elimination (Gilead) GIlead is funding approximately 30 awards to support viral hepatitis micro-elimination efforts.
Job | Program Manager – Health Policy @ Mount Sinai Funding , Jobs , Program Manager Mount Sinai School of Medicine (MSSM) was selected as the Partnership's Manhattan Borough Lead Organization.
MSSM seeks a Program Manager who will be responsible for carrying out the assigned activities and duties required under the Borough Lead Organization contract Funding | Communities Affected by Opioid Epidemic (Due 08/01/17) Funding , Opioids , Substance Abuse OMH at the U.S. Department of Health and Human Services administers cooperative agreement and grant programs to support projects that implement innovative models to improve minority health and reduce health disparities.
Funding | Hep B United Mini Grant (Deadline January 15, 2026) Funding , Grant , Hepatitis B Hep B United Mini Grants Program: 2026 Request for Funding Proposal (RFP) Application Deadline: January 15th, 2026 Expected number of awards: up to 7 The Hepatitis B Foundation is offering mini-grants for one (1) year to Hep B United coalition partners working on hepatitis B educ...
Hep Free NYC Meeting Highlights | 06-10-2026 July 7, 2026 2026 Hepatitis Awareness Month Recap May 28, 2026 Jobs | Data Coordinator @ NYC Department of Homeless Services May 8, 2026 Jobs | @ Albany Damien Center May 1, 2026 Hepatitis Awareness Month 2026 April 13, 2026 Hep Free NYC brings together stakeholders to network, share information, resources and best practices, identify needs, and develop and implement collaborative strategies to improve capacity to prevent, manage and treat hepatitis B and C in NYC.
Hep Free NYC was the 2019 Best of Brooklyn. NYC Website! You can freely give, deny, or withdraw your consent at any time by accessing the preferences panel.
Denying consent may make related features unavailable. Use the "Accept all" button to consent. Use the "Reject all" button to continue without accepting.
In this panel you can express preferences for the processing of your personal information. You may review and change your choices at any time. Required for the site to function.
Cannot be disabled. Enables enhanced functionality and personalisation such as live chats and videos. Allows us to improve your experience based on how you use the site.
Helps us measure traffic and analyse your behaviour to improve our service. Used to deliver personalised ads and marketing content based on your interests. Sale of my personal information Under US state privacy laws you may opt out of the sale of your personal information.
Sharing of my personal information Controls whether your personal information is shared with third parties. Processing for targeted advertising Allows processing of your data to deliver targeted advertising across platforms.
According to the current listing, eligibility includes: Nonprofit organizations in New York State. Confirm the full requirements in the official notice before applying.
The current listing shows $200,000 - $300,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
RFA 20620 - Expanding Harm Reduction Services for Priority Populations Who Use Drugs - Reissue Grant is funded by New York State Department of Health. Verify program details on the funder's official page before applying.
This opportunity targets applicants in New York. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
New York Providing Local Access to Essential Sustenance (NY PLATES) capital grant program is sponsored by New York State (administered by DASNY in collaboration with the New York State Department of Health, Division of Nutrition - Bureau of Nutrition Security). This program provides competitive capital grants to eligible Food Banks, Emergency Food Programs, and municipalities providing food relief services within New York's 10 regional food bank territories. Funding is for capital costs related to the design, construction, or renovation of eligible program locations, as well as for the purchase of equipment such as cold storage, freezers, and food transport vehicles, to increase capacity and improve infrastructure for hunger relief efforts. [6]
NY PLATES: New York Providing Local Access to Essential Sustenance Capital Grant Program is sponsored by New York State (administered by DASNY in collaboration with the New York State Department of Health, Division of Nutrition - Bureau of Nutrition Security). This program provides capital grants to food banks and other emergency food assistance organizations across New York State to support facility improvements, infrastructure upgrades, and equipment purchases such as cold storage, freezers, and food transport vehicles.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
HHS announced $102 million in New Access Points awards on August 13, 2026 — 158 health centers, more than 415 new sites, nearly 1 million more patients. That works out to roughly $246,000 per site, which does not build a clinic. Here is what the award actually buys, why the real selection happened before applications were scored, and what unfunded applicants should do next.
Read articleRWJF's Health Equity Research for Action puts up ~20 grants of up to $500,000 — but demands a two-year community partnership and a community co-PI. Here's the strategy, set against the brightest foundation-giving outlook since 2022.
Read articleCMS awarded all 50 states a slice of the $50 billion Rural Health Transformation Program on December 29, 2025 — first-year checks average $200M, ranging from $147M to $281M. The federal application is closed and you cannot apply to CMS. The money reaches hospitals, clinics, and nonprofits only as state subawards, and those competitions open through 2026. Here is how the formula worked, what the funds can and cannot buy, and how to position for a subaward before the money starts flowing.
Read article